publication venue for
- Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates.. 22. 2007
- Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS). 2023
- 'Secondary' acute lymphoblastic/lymphocytic leukemia - done playing second fiddle? 2023
- Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas. 2022
- Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia. 2022
- AML and the art of remission maintenance. 2021
- Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization. 2020
- The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation. 2020
- Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy. 2019
- JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia. 2019
- Time to repeal and replace response criteria for acute myeloid leukemia? 2018
- Myeloid-derived suppressor cells: The green light for myeloma immune escape. 2016
- The evolving field of prognostication and risk stratification in MDS: Recent developments and future directions. 2015
- Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma. 2014
- The double-edged sword: Neurotoxicity of chemotherapy. 2014
- Fibrinolysis and the control of blood coagulation. 2014
- Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how? 2012
- Palliative care and hematologic oncology: the promise of collaboration. 2012
- Stem cell transplantation for indolent lymphoma: a reappraisal. 2011
- The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma. 2006
- Novel approaches to refractory immune thrombocytopenic purpura. 2002
- Thrombocytosis and thrombocythemia. 2001
- CML vaccines as a paradigm of the specific immunotherapy of cancer. 2000
- Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. 1996
- Fetal and neonatal thrombocytopenia. 1995
- Biology and treatment of multiple myeloma. 1993